Eli Lilly's Orforglipron Demonstrates Superior Efficacy in Type 2 Diabetes and Weight Loss Trials The trials highlight the effectiveness of orforglipron in improving HbA1c levels and facilitating weight loss, outperforming existing treatments. This suggests potential advancements in managing type... Obesity Right to health Well-being Sep 17, 2025